indole PPAR alpha/gamma agonists (F Hoffmann-La Roche)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameindole PPAR alpha/gamma agonists (F Hoffmann-La Roche)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor α agonistsPeroxisome proliferator-activated receptor γ agonists
TargetsPeroxisome proliferator-activated receptor γPeroxisome proliferator-activated receptor α
Therapy Area/IndicationsLipid Metabolism DisordersDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsLipid Metabolism DisordersDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A